-
Medical Researchers Continue To Study Bladder Cancer As A Possible Side Effect Of Jardiance
New Analysis Finds Significant Increased Risk Of Bladder Cancer For SGLT2 Inhibitors With Empagliflozin (Posted by Tom Lamb at DrugInjuryWatch.com) For years there has been a lingering concern over whether Sodium-Glucose Co-Transporter-2…
-
Association Of Melanoma With Viagra, Cialis, Other PDE-5 Drugs: Fall 2017 Review Of Recent Medical Articles
FDA Investigation Of Potential Link Between Melanoma Skin Cancer And ED Drugs As Well BPH And PAH Medicines Continues (Posted by Tom Lamb at DrugInjuryWatch.com) From this FDA watch list of drugs…
-
Invokana – Amputations Of Lower Limbs: A Drug Side Effect Which Needs Further Explanation As Regards “How” And “Why”
Future Clinical Trials And Investigations Need To Clarify Whether This Amputation Drug Injury Could Be A Class Effect Of All SGLT2 Inhibitors (Posted by Tom Lamb at DrugInjuryWatch.com) During this year we…
-
Viberzi – Pancreatitis Side Effects Can Develop At Any Time While Taking This IBS Drug, According To FDA Safety Warning
Severe Cases Of Pancreatitis And Sphincter Of Oddi Spasm Reported Even After Just The First Dose Of Viberzi, With Some Resulting In Patient Deaths (Posted by Tom Lamb at DrugInjuryWatch.com) In March…
-
Potential Safety Signal: Rhabdomyolysis May Be Linked To Onglyza, Nesina, Januvia, And Other Diabetes Drugs
FDA Was Already Investigating The Dipeptidyl Peptidase IV (DPP-IV) Inhibitor Class Of Diabetes Drugs For Kidney Or Renal Failure (Posted by Tom Lamb at DrugInjuryWatch.com) According to a new FDA quarterly report,…